Form 8-K - Current report:
SEC Accession No. 0001193125-21-050038
Filing Date
2021-02-22
Accepted
2021-02-22 08:37:53
Documents
14
Period of Report
2021-02-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d64539d8k.htm   iXBRL 8-K 24557
2 EX-99.1 d64539dex991.htm EX-99.1 8029
6 GRAPHIC g64539g13t50.jpg GRAPHIC 3111
  Complete submission text file 0001193125-21-050038.txt   159246

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zsan-20210222.xsd EX-101.SCH 3081
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zsan-20210222_lab.xml EX-101.LAB 17373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zsan-20210222_pre.xml EX-101.PRE 10960
7 EXTRACTED XBRL INSTANCE DOCUMENT d64539d8k_htm.xml XML 3270
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

EIN.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36570 | Film No.: 21658359
SIC: 2834 Pharmaceutical Preparations